These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18437783)

  • 1. [Strange financing of HPV vaccination of girls].
    Kardel T
    Ugeskr Laeger; 2008 Mar; 170(14):1167. PubMed ID: 18437783
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy.
    Kim JJ; Kobus KE; Diaz M; O'Shea M; Van Minh H; Goldie SJ
    Vaccine; 2008 Jul; 26(32):4015-24. PubMed ID: 18602731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus (HPV) vaccination and the development of public policies.
    Lippman A
    J Epidemiol Community Health; 2008 Jul; 62(7):570-1. PubMed ID: 18559435
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus immunisation of adolescent girls and anticipated reporting of immune-mediated adverse events.
    Callréus T; Svanström H; Nielsen NM; Poulsen S; Valentiner-Branth P; Hviid A
    Vaccine; 2009 May; 27(22):2954-8. PubMed ID: 19428906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.
    Kahn JA; Cooper HP; Vadaparampil ST; Pence BC; Weinberg AD; LoCoco SJ; Rosenthal SL
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2325-32. PubMed ID: 19661092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries.
    Goldie SJ; O'Shea M; Campos NG; Diaz M; Sweet S; Kim SY
    Vaccine; 2008 Jul; 26(32):4080-93. PubMed ID: 18550229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Free HPV vaccine to young girls should be a human right in Norway!].
    Moi H
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):770. PubMed ID: 19373310
    [No Abstract]   [Full Text] [Related]  

  • 9. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.
    Biellik R; Levin C; Mugisha E; LaMontagne DS; Bingham A; Kaipilyawar S; Gandhi S
    Vaccine; 2009 Oct; 27(44):6203-9. PubMed ID: 19698808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2001-4. PubMed ID: 18825885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus vaccine legislation in Kentucky: a policy analysis.
    Dekker RL
    Policy Polit Nurs Pract; 2008 Feb; 9(1):40-9. PubMed ID: 18492941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mathematical models of cervical cancer prevention in the Asia Pacific region.
    Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ
    Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model.
    Gasparini R; Amicizia D; Manfredi P; Ansaldi F; Lucioni C; Gallelli G; Panatto D
    Epidemiol Infect; 2009 Jun; 137(6):794-802. PubMed ID: 18925989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus vaccine: a paradigm shift for pediatricians.
    Jenson HB
    Curr Opin Pediatr; 2009 Feb; 21(1):112-21. PubMed ID: 19242247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Country recommendations on the inclusion of HPV vaccines in national immunization programmes among high-income countries, June 2006-January 2008.
    Koulova A; Tsui J; Irwin K; Van Damme P; Biellik R; Aguado MT
    Vaccine; 2008 Dec; 26(51):6529-41. PubMed ID: 18805453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N; De Laet C; Hulstaert F; Neyt M; Huybrechts M; Cleemput I
    Int J Technol Assess Health Care; 2009 Apr; 25(2):161-70. PubMed ID: 19366497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India.
    Madhivanan P; Krupp K; Yashodha MN; Marlow L; Klausner JD; Reingold AL
    Vaccine; 2009 Aug; 27(38):5203-8. PubMed ID: 19596420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health and economic impact of cervical cancer screening and human papillomavirus vaccination in kidney transplant recipients.
    Wong G; Howard K; Webster A; Chapman JR; Craig JC
    Transplantation; 2009 Apr; 87(7):1078-91. PubMed ID: 19352131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
    Mennini FS; Giorgi Rossi P; Palazzo F; Largeron N
    Gynecol Oncol; 2009 Feb; 112(2):370-6. PubMed ID: 19041125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Financing HPV vaccination in developing countries.
    Lancet; 2011 May; 377(9777):1544. PubMed ID: 21550467
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.